Fortress Biotech, Inc. (FBIO) vs Tenax Therapeutics, Inc. (TENX)

Fortress Biotech, Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. Fortress Biotech, Inc. and Tenax Therapeutics, Inc. are of similar size ($61.4M and $61.0M). Tenax Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. grew revenue faster over the last twelve months: 15.5% against −70.8%. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 19 metrics below, Fortress Biotech, Inc. leads on 13 and Tenax Therapeutics, Inc. on 6.

Valuation

Metric FBIO TENX Biotechnology median
P/E 0.56 n/m 10.26
P/S 0.85 242.52 9.18
P/B 0.28 0.73 2.05
Price to free cash flow 0.68 n/m 24.81
EV/EBITDA 4.91 0.50 0.65
EV/Sales (1.46) (100.35) 8.98
Earnings yield 177.17% (90.24%) (34.89%)
Free cash flow yield 146.75% (55.21%) (24.52%)

Profitability

Metric FBIO TENX Biotechnology median
Gross margin 65.59% 0.00% 65.16%
Operating margin (42.61%) 0.00% 0.00%
Net margin 150.98% 0.00% 0.00%
Free cash flow margin 183.80% 0.00% 0.00%
Return on equity 84.91% (59.80%) (50.12%)
Return on assets 43.38% (57.02%) (45.60%)
Return on invested capital (41.34%) 0.00% 0.00%

Growth

Metric FBIO TENX Biotechnology median
Revenue growth (TTM) 15.46% (70.77%) 6.26%
EPS growth (last fiscal year) 97.40% (16.52%) 29.88%
Revenue growth, 5-year CAGR 6.77% 0.79% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FBIO TENX Biotechnology median
Debt to equity 0.17 0.00 0.00
Current ratio 3.96 15.07 4.89
Net debt to EBITDA 0.43 1.73 1.01

Dividend

Metric FBIO TENX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FBIO TENX Biotechnology median
Market cap 61.36m 61.00m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack